The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $99.33

Today's change+0.76 +0.77%
Updated June 28 4:01 PM EDT. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $99.33

Today's change+0.76 +0.77%
Updated June 28 4:01 PM EDT. Delayed by at least 15 minutes.

Core Laboratories NV up (U.S.)$0.76

Core Laboratories NV closed up Wednesday by (U.S.)$0.76 or 0.77% to (U.S.)$99.33. Over the last five days, shares have lost 1.68% and sit 3.15% above their 52-week low. This security has underperformed the S&P 500 by 35.48% during the last year.

Key company metrics

  • Open(U.S.) $98.41
  • Previous close(U.S.) $98.57
  • High(U.S.) $100.96
  • Low(U.S.) $98.35
  • Bid / Ask(U.S.) $94.75 / (U.S.) $145.00
  • YTD % change-17.25%
  • Volume432,627
  • Average volume (10-day)514,796
  • Average volume (1-month)501,314
  • Average volume (3-month)482,332
  • 52-week range(U.S.) $96.30 to (U.S.) $127.82
  • Beta1.60
  • Trailing P/E65.93×
  • P/E 1 year forward44.94×
  • Forward PEG2.25×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield2.21%
  • Trailing EPS(U.S.) $1.51
Updated June 28 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.49%Sector:EnergyIndustry:Oil Related Services & Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue158150143148
Total other revenue--------
Total revenue158150143148
Gross profit43373638
Total cost of revenue115113107110
Total operating expense135128122128
Selling / general / administrative139811
Research & development--------
Depreciation / amortization6777
Interest expense (income), net operating--------
Unusual expense (income)1000
Other operating expenses, total0000
Operating income23222120
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax21191917
Income after tax18151717
Income tax, total3421
Net income18151717
Total adjustments to net income--------
Net income before extra. items18151717
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18151717
Inc. avail. to common incl. extra. items18151717
Diluted net income18151717
Dilution adjustment--------
Diluted weighted average shares44444444
Diluted EPS excluding extraordinary itemsvalue per share0.400.350.380.38
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share0.420.350.380.38